3 completed, 1 terminated. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 3, Terminated 1 |
Follow glasdegib: new trials by email Literature Review of glasdegib trials Research Report on glasdegib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Continuation Study of B1371019(NCT03416179) and B1371012(NCT02367456) Evaluating Azacitidine With Or Without Glasdegib In Patients With Previously Untreated AML, MDS or CMML Glasdegib, Azacitidine - Acute Myeloid Leukemia, Myelodysplastic Syndrome | Phase 3 | Completed | Pfizer | 14 | 2021-05-17 | 2023-12-18 |
| Gemtuzumab Ozogamicin in Induction and Glasdegib in Postremission Therapy in Patients With AML (Acute Myeloid Leukemia) Gemtuzumab Ozogamicin 147, Gemtuzumab Ozogamicin 1, Glasdegib - Acute Myeloid Leukemia | Phase 3 | Terminated | University Hospital Heidelberg | 28 | 2021-04-01 | 2022-07-01 |
| Molecular Profiling of Advanced Soft-tissue Sarcomas Nilotinib, Ceritinib, Capmatinib - Soft Tissue Sarcoma | Phase 3 | Completed | Institut National de la Santé Et de la Recherche Médicale, France | 603 | 2019-10-19 | 2026-04-29 |
| A Study Evaluating Intensive Chemotherapy With or Without Glasdegib or Azacitidine With or Without Glasdegib In Patients With Previously Untreated Acute Myeloid Leukemia glasdegib, daunorubicin + cytarabine, azacitidine - Leukemia, Myeloid, Acute | Phase 3 | Completed | Pfizer | 730 | 2018-04-20 | 2023-04-21 |
Leukemia, Myeloid, Acute (3) · Leukemia, Myelomonocytic, Chronic (1) · Myelodysplastic Syndromes (1) · Neoplasm Metastasis (1) · Sarcoma (1)
Pfizer (2) · Institut National de la Santé Et de la Recherche Médicale, France (1) · University Hospital Heidelberg (1)
France (3) · Austria (2) · Canada (2) · Czechia (2) · Germany (2) · Hungary (2) · Italy (2) · Japan (2) · Mexico (2) · Poland (2) · Spain (2) · United Kingdom (2) · Australia (1) · Belgium (1) · China (1)
Antoine Italiano (1)
PMID 31516032, PMID 32713836, PMID 34732236, PMID 34740331, PMID 37604981
2017 (3)